Did you know...
- Prostate cancer is the most common cancer among men (after skin cancer), but it can often be treated successfully. More than 2 million men in the US count themselves as prostate cancer survivors.
- Every year, 1.2 million biopsies lead to 240,000 prostate cancer diagnoses.
- Every year, over 30,000 men die of prostate cancer.
It's time for everyone to be more educated on prostate cancer, the 2nd leading cause of cancer related death in the United States.
One of our nearest and dearest family members is around today thanks to early detection, so I am honored to spread the word for this important campaign. It's a message that needs to be heard by everyone - even women: women tend to take the dominant role in health care and screening in their homes, so we need to be more educated about prostate cancer, too.
Prolaris is a genetic test for prostate cancer from Myriad Genetics Laboratories that combines traditional risk factors with molecular assessment. It is the only test that measures how fast prostate cancer cells are dividing, and the information obtained from this test greatly impacts the treatment choices that someone diagnosed with prostate cancer would choose.